Revvity (RVTY) Non Operating Interest Expenses (2009 - 2026)
Revvity's (RVTY) quarterly Non Operating Interest Expenses came in at $25.8 million in Q3 2026, up 16.62% on a YoY basis from $22.1 million in Q3 2025, and little changed quarter-over-quarter from $25.9 million in Q2 2026.
Analysis
Revvity (RVTY) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Non Operating Interest Expenses for 13 consecutive years, with $25.8 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Non Operating Interest Expenses rose 16.62% year-over-year to $25.8 million; the trailing twelve-month figure through Jul 2026 stood at $98.1 million (up 53.38% YoY), and the FY2025 full-year result was $88.4 million, up 188.61% from the prior year.
- Non Operating Interest Expenses was little changed at $25.8 million in Q3 2026 per RVTY's latest filing, from $25.9 million in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $46.7 million in Q2 2023 and bottomed at -$2.2 million in Q3 2024.
- Historically, Non Operating Interest Expenses has averaged $23.1 million across 5 years, with a median of $25.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses slumped 114.43% in 2024, then jumped 2457.14% in 2025.
- Over 5 years, Non Operating Interest Expenses stood at $28.6 million in 2022, then surged by 59.86% to $45.8 million in 2023, then sank by 47.16% to $24.2 million in 2024, then decreased by 16.55% to $20.2 million in 2025, then grew by 27.72% to $25.8 million in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $25.8 million, $25.9 million, and $20.2 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 401.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 107.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 29.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 24.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 25.79 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 2.12 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 12.10 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 5.66 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 17.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 25.79 Mn |
| Apr 5, 2026 | 25.89 Mn |
| Dec 28, 2025 | 20.19 Mn |
| Sep 28, 2025 | 26.21 Mn |
| Jun 29, 2025 | 22.11 Mn |
| Mar 30, 2025 | 19.85 Mn |
| Dec 29, 2024 | 24.19 Mn |
| Sep 29, 2024 | -2.21 Mn |
| Jun 30, 2024 | -938,000.00 |
| Mar 31, 2024 | 9.57 Mn |
| Dec 31, 2023 | 45.78 Mn |
| Oct 1, 2023 | 18.63 Mn |
| Jul 2, 2023 | 6.50 Mn |
| Apr 2, 2023 | 46.68 Mn |
| Jan 1, 2023 | 36.13 Mn |
| Oct 2, 2022 | 28.64 Mn |
| Jul 3, 2022 | 26.15 Mn |
| Apr 3, 2022 | 37.05 Mn |
| Oct 3, 2021 | 60.55 Mn |
| Jul 4, 2021 | 6.43 Mn |